Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

for the Fondazione Italiana Linfomi and the Mantle Cell Lymphoma Network

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalBritish Journal of Haematology
Publication statusAccepted/In press - Jan 1 2018


  • allogeneic transplant
  • cytarabine
  • mantle cell lymphoma
  • prognosis
  • refractory

ASJC Scopus subject areas

  • Hematology

Cite this